Anticancer drug containing alpha,alpha,alpha-trifluorothymidine and thymidine phosphorylase inhibitor
Details for Australian Patent Application No. 2006209547 (hide)
International Classifications
Event Publications
16 August 2007 PCT application entered the National Phase
PCT publication WO2006/080327 Priority application(s): WO2006/080327
26 May 2011 Application Accepted
Published as AU-B-2006209547
22 September 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006209556-Process for production of 5-chloro-2,4-dihydroxypyridine
2006209543-Six-membered heterocyclic compound and the use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser